These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3212388)

  • 1. Synergistic growth-inhibitory activity of tumour necrosis factor and alpha interferon. Contribution to the monocyte-derived cytostatic activity towards human leukaemia K562 cells.
    Nissen-Meyer J; Austgulen R; Espevik T
    Scand J Immunol; 1988 Nov; 28(5):627-37. PubMed ID: 3212388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte-derived influence on growth of normal human fibroblasts. The contribution of tumour necrosis factor to growth inhibition.
    Austgulen R; Nissen-Meyer J; Degré M; Espevik T
    Scand J Immunol; 1987 Aug; 26(2):175-85. PubMed ID: 3114873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antisera against recombinant tumor necrosis factor and the monocyte-derived cytotoxin(s) on monocyte-mediated killing of various tumor cells.
    Nissen-Meyer J; Espevik T
    Cell Immunol; 1987 Oct; 109(2):384-96. PubMed ID: 3478143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of recombinant tumor necrosis factor and the monocyte-derived cytotoxic factor involved in monocyte-mediated cytotoxicity.
    Nissen-Meyer J; Austgulen R; Espevik T
    Cancer Res; 1987 May; 47(9):2251-8. PubMed ID: 3567918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileukemic effect of recombinant tumor necrosis factor alpha in vitro and its modulation by alpha and gamma interferons.
    Beran M; McCredie KB; Keating MJ; Gutterman JU
    Blood; 1988 Aug; 72(2):728-38. PubMed ID: 3135864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
    Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R
    Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential cytostatic activity of monocyte-derived cytokines against human melanoma cells.
    te Velde AA; vd Wiel-v Kemenade E; Figdor CG
    Int J Cancer; 1992 Mar; 50(5):746-51. PubMed ID: 1544709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic enhancement of class I major histocompatibility complex antigen expression in K562 cells induced by recombinant human interferon-gamma and tumor necrosis factor in combination.
    Takemura Y; Koide Y; Kawabata M; Kitajima S; Ohba C; Suzuki H; Sekiguchi S
    Exp Hematol; 1989 Aug; 17(7):795-9. PubMed ID: 2502422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
    van de Loosdrecht AA; Beelen RH; Ossenkoppele GJ; Broekhoven MG; Langenhuijsen MM
    Exp Hematol; 1993 Mar; 21(3):461-8. PubMed ID: 8440344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A physico-chemical comparison of the monocyte-derived fibroblast growth factor and the tumour necrosis factor.
    Austgulen R; Nissen-Meyer J
    APMIS; 1988 Apr; 96(4):352-6. PubMed ID: 3370158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1.
    Morikawa K; Fidler IJ
    J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.
    Espevik T; Nissen-Meyer J
    J Immunol Methods; 1986 Dec; 95(1):99-105. PubMed ID: 3782828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour necrosis factor-like activity on paraformaldehyde-fixed monocyte monolayers.
    Espevik T; Nissen-Meyer J
    Immunology; 1987 Aug; 61(4):443-8. PubMed ID: 3443451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity of the effect of recombinant tumor necrosis factors alpha and beta on human myelogenous leukemia cell lines.
    Beran M; Andersson BS; Kelleher P; Whalen K; McCredie K; Gutterman J
    Blood; 1987 Mar; 69(3):721-6. PubMed ID: 3028534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incubation of human blood monocytes with tumor necrosis factor-alpha leads to lysis of tumor necrosis factor-sensitive but not resistant tumor cells.
    Nii A; Fidler IJ
    Lymphokine Res; 1990; 9(2):113-24. PubMed ID: 2338840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin.
    Ortaldo JR; Ransom JR; Sayers TJ; Herberman RB
    J Immunol; 1986 Nov; 137(9):2857-63. PubMed ID: 3093586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of receptors for tumor necrosis factor-alpha by interferons is not a major mechanism for their synergistic cytotoxic response.
    Aggarwal BB; Eessalu TE
    J Biol Chem; 1987 Jul; 262(21):10000-7. PubMed ID: 2440858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth-stimulatory activity released from human monocytes. The contribution of tumour necrosis factor.
    Austgulen R; Espevik T; Nissen-Meyer J
    Scand J Immunol; 1987 Dec; 26(6):621-9. PubMed ID: 3423739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of monocyte antigen-presenting capacity by tumour necrosis factor-alpha (TNF): opposing effects of exogenous TNF before and after an antigen pulse and the role of TNF gene activation in monocytes.
    Kowalczyk D; Mytar B; Jasiński M; Pryjma J; Zembala M
    Immunol Lett; 1995 Jan; 44(1):51-7. PubMed ID: 7721344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.